Financial reports
10-Q
2013 Q2
Quarterly report
7 Aug 13
ARS
2012 FY
Annual report to shareholders
20 May 13
10-Q
2013 Q1
Quarterly report
8 May 13
10-K
2012 FY
Annual report
13 Mar 13
10-Q
2012 Q3
Quarterly report
7 Nov 12
10-Q
2012 Q2
Quarterly report
7 Aug 12
ARS
2011 FY
Annual report to shareholders
14 May 12
10-Q
2012 Q1
Quarterly report
9 May 12
10-K
2011 FY
Annual report
14 Mar 12
10-Q
2011 Q3
Quarterly report
10 Nov 11
Current reports
8-K
Completion of Acquisition or Disposition of Assets
11 Sep 13
8-K
Trius Therapeutics Reports Second Quarter 2013 Financial Results
6 Aug 13
8-K
Entry into a Material Definitive Agreement
1 Aug 13
8-K
Entry into a Material Definitive Agreement
25 Jul 13
8-K
Departure of Directors or Certain Officers
24 May 13
8-K
Trius Therapeutics Reports First Quarter 2013 Financial Results
7 May 13
8-K
Trius Appoints Seth Fischer to Its Board of Directors
3 Apr 13
8-K
Trius Announces Positive Results from Establish 2 Study of
25 Mar 13
8-K
Departure of Directors or Certain Officers
13 Mar 13
8-K
Trius Therapeutics Reports 2012 Fourth Quarter and Full Year 2012 Financial Results
12 Mar 13
Registration and prospectus
15-12B
Securities registration termination
23 Sep 13
POS AM
Prospectus update (post-effective amendment)
13 Sep 13
POS AM
Prospectus update (post-effective amendment)
13 Sep 13
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Sep 13
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Sep 13
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Sep 13
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Sep 13
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Sep 13
25-NSE
Exchange delisting
11 Sep 13
SC 14D9/A
Tender offer solicitation (amended)
11 Sep 13
Proxies
DEF 14A
Definitive proxy
15 Apr 13
DEF 14A
Definitive proxy
12 Apr 12
DEF 14A
Definitive proxy
20 Apr 11
Other
CT ORDER
Confidential treatment order
10 Oct 13
EFFECT
Notice of effectiveness
16 Sep 13
EFFECT
Notice of effectiveness
16 Sep 13
CT ORDER
Confidential treatment order
16 Jul 13
EFFECT
Notice of effectiveness
11 Sep 12
UPLOAD
Letter from SEC
9 Mar 12
CORRESP
Correspondence with SEC
17 Feb 12
CT ORDER
Confidential treatment order
18 Jan 12
CORRESP
Correspondence with SEC
13 Jan 12
UPLOAD
Letter from SEC
29 Dec 11
Ownership
SC 13G/A
Trius Therapeutics Inc
14 Feb 14
SC 13D/A
Trius Therapeutics Inc
13 Sep 13
SC 13D/A
Trius Therapeutics Inc
26 Aug 13
SC 13D
Trius Therapeutics Inc
9 Aug 13
SC 13D/A
SOFINNOVA VENTURE PARTNERS VII L P
13 Jan 12
SC 13D/A
SOFINNOVA VENTURE PARTNERS VII L P
6 Dec 11
SC 13D
InterWest Partners IX, LP
16 Aug 10
SC 13D
SOFINNOVA VENTURE PARTNERS VII L P
16 Aug 10